Intraperitoneal levobupivacaine and dexamethasone for post-operative pain after laparoscopic cholecystectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN80508655

Enrollment

Registered

2005-09-30

Start date

2004-10-01

Completion date

Unknown

Last updated

2016-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Signs and Symptoms: Post operative pain Signs and Symptoms Pain, not elsewhere classified

Interventions

Randomised Controlled Trial. 3 groups: 1. Control group will not receive intraperitoneal local anaesthetic or dexamethasone as is our usual practice 2. L group will receive 15 ml of 0,5% levobupivac

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing Laparoscopic Cholecystectomy

Exclusion criteria

Exclusion criteria: 1. Patients allergic to local anaesthetics or dexamethasone, ASA IV and V patients. 2. Patients with acute cholecystitis 3. Patients with previous laparotomy, any intraoperative complications like perforation of the gall bladder, major vascular injury and any procedure which is converted to an open one

Design outcomes

Primary

Measure	Time frame
Pain Scores	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026